282 related articles for article (PubMed ID: 27646277)
1. Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia.
Baeyens N; Larrivée B; Ola R; Hayward-Piatkowskyi B; Dubrac A; Huang B; Ross TD; Coon BG; Min E; Tsarfati M; Tong H; Eichmann A; Schwartz MA
J Cell Biol; 2016 Sep; 214(7):807-16. PubMed ID: 27646277
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.
Sugden WW; Siekmann AF
Curr Opin Hematol; 2018 May; 25(3):237-244. PubMed ID: 29438260
[TBL] [Abstract][Full Text] [Related]
4. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
[TBL] [Abstract][Full Text] [Related]
5. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
[TBL] [Abstract][Full Text] [Related]
6. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
[TBL] [Abstract][Full Text] [Related]
7. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
[TBL] [Abstract][Full Text] [Related]
8. Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions.
Peacock HM; Caolo V; Jones EA
Cardiovasc Res; 2016 Feb; 109(2):196-203. PubMed ID: 26645978
[TBL] [Abstract][Full Text] [Related]
9. ALK1 signaling in development and disease: new paradigms.
Roman BL; Hinck AP
Cell Mol Life Sci; 2017 Dec; 74(24):4539-4560. PubMed ID: 28871312
[TBL] [Abstract][Full Text] [Related]
10. Impaired SMAD1/5 Mechanotransduction and Cx37 (Connexin37) Expression Enable Pathological Vessel Enlargement and Shunting.
Peacock HM; Tabibian A; Criem N; Caolo V; Hamard L; Deryckere A; Haefliger JA; Kwak BR; Zwijsen A; Jones EAV
Arterioscler Thromb Vasc Biol; 2020 Apr; 40(4):e87-e104. PubMed ID: 32078368
[TBL] [Abstract][Full Text] [Related]
11. Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
Gallardo-Vara E; Tual-Chalot S; Botella LM; Arthur HM; Bernabeu C
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108051
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology.
Ruiz S; Chandakkar P; Zhao H; Papoin J; Chatterjee PK; Christen E; Metz CN; Blanc L; Campagne F; Marambaud P
Hum Mol Genet; 2017 Dec; 26(24):4786-4798. PubMed ID: 28973643
[TBL] [Abstract][Full Text] [Related]
13. Defective Flow-Migration Coupling Causes Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
Park H; Furtado J; Poulet M; Chung M; Yun S; Lee S; Sessa WC; Franco CA; Schwartz MA; Eichmann A
Circulation; 2021 Sep; 144(10):805-822. PubMed ID: 34182767
[TBL] [Abstract][Full Text] [Related]
14. PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia.
Ola R; Dubrac A; Han J; Zhang F; Fang JS; Larrivée B; Lee M; Urarte AA; Kraehling JR; Genet G; Hirschi KK; Sessa WC; Canals FV; Graupera M; Yan M; Young LH; Oh PS; Eichmann A
Nat Commun; 2016 Nov; 7():13650. PubMed ID: 27897192
[TBL] [Abstract][Full Text] [Related]
15. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
[TBL] [Abstract][Full Text] [Related]
16. Shear Stress and Sub-Femtomolar Levels of Ligand Synergize to Activate ALK1 Signaling in Endothelial Cells.
Cheng YW; Anzell AR; Morosky SA; Schwartze TA; Hinck CS; Hinck AP; Roman BL; Davidson LA
Cells; 2024 Feb; 13(3):. PubMed ID: 38334677
[TBL] [Abstract][Full Text] [Related]
17. Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
Genet G; Genet N; Paila U; Cain SR; Cwiek A; Chavkin NW; Serbulea V; Figueras A; Cerdà P; McDonnell SP; Sankaranarayanan D; Huba M; Nelson EA; Riera-Mestre A; Hirschi KK
Circulation; 2024 Mar; 149(12):944-962. PubMed ID: 38126211
[TBL] [Abstract][Full Text] [Related]
18. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
[TBL] [Abstract][Full Text] [Related]
19. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
David L; Mallet C; Mazerbourg S; Feige JJ; Bailly S
Blood; 2007 Mar; 109(5):1953-61. PubMed ID: 17068149
[TBL] [Abstract][Full Text] [Related]
20. Interaction Between ALK1 Signaling and Connexin40 in the Development of Arteriovenous Malformations.
Gkatzis K; Thalgott J; Dos-Santos-Luis D; Martin S; Lamandé N; Carette MF; Disch F; Snijder RJ; Westermann CJ; Mager JJ; Oh SP; Miquerol L; Arthur HM; Mummery CL; Lebrin F
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):707-17. PubMed ID: 26821948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
